FIELD: chemistry.
SUBSTANCE: invention relates to a novel compound of formula (II), which has the properties of a cell proliferation inhibitor. Fabric or organ fibrosis is renal interstitial fibrosis, glomerulosclerosis, hepatic fibrosis, pneumosclerosis, IPF, peritoneal fibrosis, myocardial fibrosis, dermatofibrosis, skeletal muscle fibrosis, pancreatic fibrosis, hepatic cirrhosis, myosarcoma, neurofibroma, pulmonary interstitial fibrosis, or vascular fibrosis. In formula (II)
,
where each of Q1 and Q2 independently represents N or CH; J is -O- or -(CH2)m-; Y is -O-, -(CH2)m-O-, -N(R6) - or -(CH2)m-; where each is (CH2)m-O- and -(CH2)m- independently and optionally substituted with one or more substitutes independently selected from C1-4 alkyl, each R5 independently represents
,
where each E1, E2 and E3 independently represents N or CR7; each T and T1 independently represents -NR8-, -O-, -S- or -CR7R7a-; each R7 and R7a independently represents H; where each R5 independently and additionally substituted with one or more substituents independently selected from H, F, Cl, Br, I, C1-4 alkyl, C2-4 alkenyl, C1-4 alkoxy, C1-4 haloalkyl, cyano, amino, C1-4 alkylamino, phenyl, and C1-4 haloalkoxy; each R6 independently represents H or C1-4 alkyl; each R8 independently represents H; each R1a is independently H, F, Cl, Br, or I; R3 is methyl, ethyl, propyl, butyl, or tert-butyl; and each R4 is independently H, F, Cl, Br, or I; each m is independently 1 or 2; and each n or p is independently 0, 1, 2, 3 or 4.
EFFECT: compound can be used in preparing a medicinal agent for preventing, controlling, treating or relieving the severity of tissue or organ fibrosis.
11 cl, 1 tbl, 69 ex
Title | Year | Author | Number |
---|---|---|---|
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND USE THEREOF IN PHARMACEUTICAL PREPARATIONS | 2013 |
|
RU2701156C2 |
NOVEL PYRIDOPYRIMIDINONE COMPOUNDS FOR MODULATION OF CATALYTIC ACTIVITY OF HISTONE LYSINE DEMETHYLASES (KDMS) | 2015 |
|
RU2684396C2 |
INFLUENZA VIRUS REPLICATION INHIBITORS, METHODS OF APPLICATION AND USING | 2016 |
|
RU2737190C2 |
DIHYDROPYRIMIDIN COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS | 2013 |
|
RU2655914C9 |
SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | 2014 |
|
RU2675105C9 |
PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATE PRODUCTS THEREOF | 2014 |
|
RU2697707C1 |
SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITOR | 2014 |
|
RU2671212C2 |
PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATE COMPOUNDS THEREOF | 2014 |
|
RU2688193C1 |
ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS | 2011 |
|
RU2535671C1 |
PROCESS FOR PREPARATION OF N-[(3-AMINOOXETAN-3-YL)METHYL]-2-(1,1-DIOXO-3,5-DIHYDRO-1,4-BENZOTHIAZEPINE-4-YL)-6-METHYL-QUINAZOLINE-4-AMINE | 2015 |
|
RU2664643C2 |
Authors
Dates
2019-07-11—Published
2014-12-19—Filed